Meta: Ponvory treatment for up to 13 years was associated with low MS disease activity in adults with relapsing-remitting multiple sclerosis.

Early treatment with high-efficacy MS drugs cut the risk of relapse, but not disability progression independent of relapse ...

Novartis (NVS) stock gains as late-stage trials for hives therapy Rhapsido meet main goals in patients with multiple sclerosis. Read more here.

Scientists hunting for treatments and cures for multiple sclerosis may have found an unlikely ally — the yak. The high-altitude, cold-hardy relative of the cow could be the key to a medical ...

A therapeutic approach pioneered in Mainz for the treatment of multiple sclerosis (MS) is taking an important step toward clinical application.

Multiple sclerosis (MS) is a chronic disease of the central nervous system that causes disruptions in the flow of information within the brain and between the brain and body, eventually causing ...

Add Yahoo as a preferred source to see more of our stories on Google. BUFFALO, N.Y. (WIVB) — More than a thousand people gathered at Terminal B at the Outer Harbor with one goal in mind Saturday ...

HOUSTON & WALTHAM, Mass.--(BUSINESS WIRE)--Biostate AI, a leading innovator in artificial intelligence for RNA sequencing, today announced a strategic partnership with the Accelerated Cure Project ...

WALTHAM, Mass., March 12, 2025 /PRNewswire/ -- People who are caring for loved ones with multiple sclerosis (MS) now have an additional resource to answer their questions at any time. In addition to ...